Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
Nat Commun ; 5: 5056, 2014 Oct 03.
Article in English | MEDLINE | ID: mdl-25278028

ABSTRACT

Genome-wide association studies implicate dysregulation of immune mechanisms in the pathogenesis of multiple sclerosis (MS). Particularly, polymorphisms in genes involved in T helper (TH) cell differentiation are associated with risk of developing MS. However, the underlying mechanism by which these risk alleles influence MS susceptibility has remained elusive. Initiation of neuroinflammation in animal models of MS has been shown to be dependent on TH cell-derived granulocyte-macrophage colony-stimulating factor (GM-CSF). We here report association of GM-CSF expression by human TH cells with MS disease severity. GM-CSF is strongly induced by interleukin 2 (IL-2). We show that an MS-associated polymorphism in the IL-2 receptor alpha (IL2RA) gene specifically increases the frequency of GM-CSF-producing TH cells. The IL2RA polymorphism regulates IL-2 responsiveness of naive TH cells and their propensity to develop into GM-CSF-producing memory TH cells. These findings mechanistically link an immunologically relevant genetic risk factor with a functional feature of TH cells in MS.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/biosynthesis , Interleukin-2 Receptor alpha Subunit/genetics , Multiple Sclerosis/genetics , Cell Proliferation , Flow Cytometry , Genome-Wide Association Study , Genotype , Healthy Volunteers , Humans , Interleukin-2/metabolism , Leukocytes, Mononuclear/cytology , Multiple Sclerosis/metabolism , Phosphorylation , Polymorphism, Genetic , STAT5 Transcription Factor/metabolism , T-Lymphocytes/cytology , T-Lymphocytes, Helper-Inducer/cytology
2.
Int Immunol ; 25(10): 553-61, 2013 Oct.
Article in English | MEDLINE | ID: mdl-23728776

ABSTRACT

Mast cells are able to trigger life-saving immune responses in murine models for acute inflammation. In such settings, several lines of evidence indicate that the rapid and protective recruitment of neutrophils initiated by the release of mast cell-derived pro-inflammatory mediators is a key element of innate immunity. Herein, we investigate the impact of mast cells on critical parameters of neutrophil effector function. In the presence of activated murine bone marrow-derived mast cells, neutrophils freshly isolated from bone marrow rapidly lose expression of CD62L and up-regulate CD11b, the latter being partly driven by mast cell-derived TNF and GM-CSF. Mast cells also strongly enhance neutrophil phagocytosis and generation of reactive oxygen species. All these phenomena partly depend on mast cell-derived TNF and to a greater extend on GM-CSF. Furthermore, spontaneous apoptosis of neutrophils is greatly diminished due to the ability of mast cells to deliver antiapoptotic GM-CSF. Finally, we show in a murine model for acute lung inflammation that neutrophil phagocytosis is impaired in mast cell-deficient Kit (W-sh) /Kit (W-sh) mice but can be restored upon mast cell engraftment. Thus, a previously underrated feature of mast cells is their ability to boost neutrophil effector functions in immune responses.


Subject(s)
Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Mast Cells/immunology , Neutrophils/immunology , Pneumonia/immunology , Tumor Necrosis Factor-alpha/metabolism , Animals , Apoptosis , Cells, Cultured , Flow Cytometry , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Mice, Mutant Strains , Neutrophil Activation/genetics , Phagocytosis/genetics , Tumor Necrosis Factor-alpha/genetics
3.
Am J Respir Crit Care Med ; 187(12): 1349-59, 2013 Jun 15.
Article in English | MEDLINE | ID: mdl-23590269

ABSTRACT

RATIONALE: Natural killer (NK) cells are innate lymphocytes that target virus-infected and tumor cells. Much less is known about their ability to limit adaptive immune responses. OBJECTIVES: Thus, we investigated to what extent NK cells can influence mouse lung allograft rejection. METHODS: For this purpose, we employed an orthotopic lung transplantation model in mice. MEASUREMENTS AND MAIN RESULTS: We demonstrate here that NK cells infiltrate mouse lung allografts before T cells and thereby diminished allograft inflammation, and that NK-cell deficiency enhanced allograft rejection. In contrast, expansion of recipient NK cells through IL-15/IL-15Rα complex treatment resulted in decreased T-cell infiltration and alloreactive T-cell priming as well as improved function of the allogeneic lung transplant. Only perforin-competent, but not perforin-deficient, NK cells were able to transfer these beneficial effects into transplanted NK cell-deficient IL-15Rα(-/-) mice. These NK cells killed allogeneic dendritic cells (DCs) in vitro and significantly decreased the number of allogeneic DCs in transplanted lungs in vivo. Furthermore, DC-depleted lung allografts presented decreased signs of rejection. CONCLUSIONS: These results suggest that NK cells favor allograft acceptance by depleting donor-derived DCs, which otherwise would prime alloreactive T-cell responses. Thus, conditioning regimens that augment NK-cell reactivity should be clinically explored to prepare lung allograft recipients.


Subject(s)
Dendritic Cells , Graft Rejection/immunology , Interleukin-15/immunology , Killer Cells, Natural/immunology , Lung Transplantation/immunology , Animals , Mice , Receptors, Interleukin-15/immunology
4.
Trends Immunol ; 34(3): 114-9, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23116549

ABSTRACT

Clinical and experimental data suggest that T helper (TH) cells are involved in the pathogenicity of experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis (MS), but it is unlikely that they are directly responsible for the observed demyelination and axonal loss. Instead, the cell population that targets the destruction of oligodendrocytes and axons, and the mechanism exploited by central nervous system (CNS)-invading encephalitogenic TH cells to instruct these cells to mediate tissue damage, are still under debate. Mature myeloid cells form a prominent component of the neuroinflammatory infiltrates and are the suspected culprits behind the CNS injury due to their arsenal of toxic factors. Here, we describe the process of encephalitogenic TH cell activation followed by their entry into the CNS and discuss how pathogenic TH cells influence the myeloid compartment.


Subject(s)
Cell Communication , Encephalomyelitis, Autoimmune, Experimental/pathology , Multiple Sclerosis/pathology , Myeloid Cells/cytology , T-Lymphocytes/cytology , T-Lymphocytes/pathology , Animals , Encephalomyelitis, Autoimmune, Experimental/immunology , Humans , Lymphocyte Activation , Mice , Multiple Sclerosis/immunology , Myeloid Cells/immunology , Myeloid Cells/pathology , T-Lymphocytes/immunology
5.
Clin J Am Soc Nephrol ; 6(8): 2025-33, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21757642

ABSTRACT

BACKGROUND AND OBJECTIVES: In humans, circulating CD4(+)CD25(high) T cells contain mainly regulatory T cells (Treg; FoxP3(+)IL-7Rα(low)), but a small subset is represented by activated effector T cells (Tact; FoxP3(-)IL-7Rα(high)). The balance between Tact and Treg may be important after transplantation. The aim of this study was first to analyze and correlate CD4(+)CD25(high) Tact and Treg with the clinical status of kidney transplant recipients and second to study prospectively the effect of two immunosuppressive regimens on Tact/Treg during the first year after transplantation. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: CD4(+)CD25(high) Tact and Treg were analyzed by flow cytometry, either retrospectively in 90 patients greater than 1 year after kidney transplantation (cross-sectional analysis) or prospectively in 35 patients receiving two immunosuppressive regimens after kidney transplantation (prospective analysis). RESULTS: A higher proportion of Tact and a lower proportion of Treg were found in the majority of kidney recipients. In chronic humoral rejection, a strikingly higher proportion of Tact was present. A subgroup of stable recipients receiving calcineurin inhibitor-free immunosuppression (mycophenolate mofetil, azathioprine, or sirolimus) had Tact values that were similar to healthy individuals. In the prospective analysis, the proportion of Tact significantly increased in both immunosuppression groups during the first year after transplantation. CONCLUSIONS: These data highlight distinct patterns in the proportion of circulating Tact depending on the clinical status of kidney recipients. Moreover, the prospective analysis demonstrated an increase in the proportion of Tact, regardless of the immunosuppressive regimen. The measurement of Tact, in addition to Treg, may become a useful immune monitoring tool after kidney transplantation.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Interleukin-2 Receptor alpha Subunit/blood , Kidney Transplantation/immunology , Lymphocyte Activation , Receptors, Interleukin-7/blood , Adolescent , Adult , Aged , Biomarkers/blood , CD4-Positive T-Lymphocytes/drug effects , Child , Child, Preschool , Drug Therapy, Combination , Female , Flow Cytometry , Graft Rejection/immunology , Graft Rejection/prevention & control , Graft Survival , Humans , Immunity, Cellular , Immunity, Humoral , Immunophenotyping , Immunosuppressive Agents/therapeutic use , Lymphocyte Activation/drug effects , Lymphocyte Count , Male , Middle Aged , Monitoring, Immunologic/methods , Prospective Studies , Retrospective Studies , Switzerland , T-Lymphocytes, Regulatory/immunology , Time Factors , Treatment Outcome , Young Adult
6.
Nat Immunol ; 12(6): 560-7, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21516112

ABSTRACT

Although the role of the T(H)1 and T(H)17 subsets of helper T cells as disease mediators in autoimmune neuroinflammation remains a subject of some debate, none of their signature cytokines are essential for disease development. Here we report that interleukin 23 (IL-23) and the transcription factor RORγt drove expression of the cytokine GM-CSF in helper T cells, whereas IL-12, interferon-γ (IFN-γ) and IL-27 acted as negative regulators. Autoreactive helper T cells specifically lacking GM-CSF failed to initiate neuroinflammation despite expression of IL-17A or IFN-γ, whereas GM-CSF secretion by Ifng(-/-)Il17a(-/-) helper T cells was sufficient to induce experimental autoimmune encephalomyelitis (EAE). During the disease effector phase, GM-CSF sustained neuroinflammation via myeloid cells that infiltrated the central nervous system. Thus, in contrast to all other known helper T cell-derived cytokines, GM-CSF serves a nonredundant function in the initiation of autoimmune inflammation regardless of helper T cell polarization.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/metabolism , Granulocyte-Macrophage Colony-Stimulating Factor/metabolism , Nuclear Receptor Subfamily 1, Group F, Member 3/metabolism , T-Lymphocytes, Helper-Inducer/metabolism , Animals , Cells, Cultured , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/immunology , Female , Flow Cytometry , Glycoproteins , Granulocyte-Macrophage Colony-Stimulating Factor/genetics , Granulocyte-Macrophage Colony-Stimulating Factor/immunology , Interferon-gamma/genetics , Interferon-gamma/immunology , Interferon-gamma/pharmacology , Interleukin-12/pharmacology , Interleukin-17/genetics , Interleukin-17/immunology , Interleukin-23/pharmacology , Interleukins/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Inbred Strains , Mice, Knockout , Mice, Transgenic , Myelin-Oligodendrocyte Glycoprotein , Nuclear Receptor Subfamily 1, Group F, Member 3/genetics , Nuclear Receptor Subfamily 1, Group F, Member 3/immunology , Peptide Fragments , T-Lymphocytes, Helper-Inducer/immunology , Th1 Cells/drug effects , Th1 Cells/immunology , Th1 Cells/metabolism , Th17 Cells/drug effects , Th17 Cells/immunology , Th17 Cells/metabolism
7.
J Theor Biol ; 266(2): 307-22, 2010 Sep 21.
Article in English | MEDLINE | ID: mdl-20600134

ABSTRACT

Despite their limited proliferation capacity, regulatory T cells (T(regs)) constitute a population maintained over the entire lifetime of a human organism. The means by which T(regs) sustain a stable pool in vivo are controversial. Using a mathematical model, we address this issue by evaluating several biological scenarios of the origins and the proliferation capacity of two subsets of T(regs): precursor CD4(+)CD25(+)CD45RO(-) and mature CD4(+)CD25(+)CD45RO(+) cells. The lifelong dynamics of T(regs) are described by a set of ordinary differential equations, driven by a stochastic process representing the major immune reactions involving these cells. The model dynamics are validated using data from human donors of different ages. Analysis of the data led to the identification of two properties of the dynamics: (1) the equilibrium in the CD4(+)CD25(+)FoxP3(+)T(regs) population is maintained over both precursor and mature T(regs) pools together, and (2) the ratio between precursor and mature T(regs) is inverted in the early years of adulthood. Then, using the model, we identified three biologically relevant scenarios that have the above properties: (1) the unique source of mature T(regs) is the antigen-driven differentiation of precursors that acquire the mature profile in the periphery and the proliferation of T(regs) is essential for the development and the maintenance of the pool; there exist other sources of mature T(regs), such as (2) a homeostatic density-dependent regulation or (3) thymus- or effector-derived T(regs), and in both cases, antigen-induced proliferation is not necessary for the development of a stable pool of T(regs). This is the first time that a mathematical model built to describe the in vivo dynamics of regulatory T cells is validated using human data. The application of this model provides an invaluable tool in estimating the amount of regulatory T cells as a function of time in the blood of patients that received a solid organ transplant or are suffering from an autoimmune disease.


Subject(s)
Autoimmune Diseases/immunology , Homeostasis/immunology , Models, Immunological , T-Lymphocytes, Regulatory/immunology , Transplantation Immunology/immunology , Adult , Aged , Cell Count , Cell Differentiation/immunology , Cell Proliferation , Female , Flow Cytometry , Humans , Male , Middle Aged , T-Lymphocyte Subsets/immunology , Thymus Gland/immunology , Time Factors
8.
Curr Opin Neurol ; 23(3): 205-11, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20442570

ABSTRACT

PURPOSE OF REVIEW: This review will discuss aspects of cytokine networks in neuroinflammatory diseases and attempt to provide some explanation for our failures and successes in translating preclinical data to benefit patients with multiple sclerosis (MS). We will discuss innate cytokines such as tumor necrosis factor alpha and interferon (IFN) beta and will then go on to cover recent findings on the role of interleukin-23 and the so-called T(H)17 cells and how they are implicated in the pathogenesis of neuroinflammation. RECENT FINDINGS: Even though IFN-beta has been used for the treatment of MS for many years, it is only recently that the mechanistic underpinnings of the IFN-beta-mediated immune modulation was discovered in preclinical models. The timeline is at odds with the idea that preclinical data should shape the design of therapeutic strategies in the clinic. Conversely, the discovery of the so-called T(H)17 cells and their association with neuroinflammation has broken the dogma that IFN-gamma-producing T(H)1 cells have the exclusive capacity to invade and destroy the central nervous system tissue. So why then did a clinical trial targeting the T(H)17-promoting cytokine interleukin-23 fail? SUMMARY: Preclinical studies using the animal models for MS have yielded promising results, but unfortunately the translation into the clinic is often disappointing. The reason for this may be the complex nature of the pathogenesis of autoimmune neuroinflammation, but more often an oversimplified interpretation of preclinical observations appears to hinder our progress.


Subject(s)
Cytokines/metabolism , Demyelinating Autoimmune Diseases, CNS/immunology , Inflammation/immunology , Multiple Sclerosis/immunology , Translational Research, Biomedical/methods , Animals , Cytokines/genetics , Demyelinating Autoimmune Diseases, CNS/pathology , Demyelinating Autoimmune Diseases, CNS/physiopathology , Disease Models, Animal , Drug Evaluation, Preclinical/methods , Drug Evaluation, Preclinical/trends , Humans , Immunologic Factors/pharmacology , Immunologic Factors/therapeutic use , Inflammation/pathology , Inflammation/physiopathology , Multiple Sclerosis/pathology , Multiple Sclerosis/physiopathology , T-Lymphocytes, Helper-Inducer/drug effects , T-Lymphocytes, Helper-Inducer/immunology , Translational Research, Biomedical/trends
9.
Liver Transpl ; 16(1): 49-55, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19866484

ABSTRACT

The expression of interleukin 7 receptor alpha(high) (IL-7Ralpha(high)) discriminates between activated CD25(+)CD45RO(+)CD4(+) T cells [IL-7Ralpha(high) and forkhead box P3-negative (FoxP3(-))] and regulatory T cells (IL-7Ralpha(low) and FoxP3(+)). The IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population has been shown to be expanded in the blood and tissues of patients after kidney transplantation and to contain alloreactive T cells (activated T cells). In the present study, we analyzed the distribution of IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cells in the blood of 53 patients after liver transplantation. The IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population was significantly expanded (P < 0.0001) in stable transplant recipients versus healthy donors. However, the magnitude of the expansion was significantly higher (P < 0.0001) in liver transplant recipients with no hepatitis C virus (HCV) infection in comparison with those with a preexisting HCV infection. Interestingly, effective suppression of HCV viremia after antiviral therapy was associated with an increase in the IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population to levels comparable to those of liver transplant recipients not infected with HCV. The present results indicate that (1) the IL-7Ralpha(high)CD25(+)CD45RO(+)CD4(+)FoxP3(-) T cell population is expanded after liver transplantation, (2) it is a valuable immunological marker for monitoring activated and potential alloreactive CD4 T cells in liver transplantation, and (3) a preexisting HCV infection negatively influences the expansion of this population in liver transplant recipients.


Subject(s)
Hepatitis C, Chronic/immunology , Interleukin-7 Receptor alpha Subunit/metabolism , Liver Transplantation , Postoperative Complications/immunology , T-Lymphocytes, Regulatory/metabolism , Adult , Aged , Antiviral Agents/therapeutic use , Case-Control Studies , Down-Regulation , Female , Hepatitis C, Chronic/drug therapy , Humans , Male , Middle Aged , Young Adult
10.
Proc Natl Acad Sci U S A ; 104(41): 16233-8, 2007 Oct 09.
Article in English | MEDLINE | ID: mdl-17911249

ABSTRACT

We studied CD8 T cell responses against HIV-1, cytomegalovirus, Epstein-Barr virus, and influenza in 128 subjects and demonstrate that polyfunctional CD8 T cell responses, also including IL-2 production and Ag-specific proliferation, are predominantly driven by virus epitopes restricted by HLA-B alleles. Interestingly, these protective CD8 T cells are equipped with low-avidity T cell receptors (TCRs) for the cognate virus epitope. Conversely, HLA-A-restricted epitopes are mostly associated with "only effector" IFN-gamma-secreting, with cytotoxicity, and with the lack of IL-2 production and Ag-specific proliferation. These CD8 T cells are equipped with high-avidity TCR and express higher levels of the T cell exhaustion marker PD-1. Thus, the functional profile of the CD8 T cell response is strongly influenced by the extent to which there is stimulation of polyfunctional (predominantly restricted by HLA-B) versus only effector (restricted by HLA-A) T cell responses. These results provide the rationale for the observed protective role of HLA-B in HIV-1-infection and new insights into the relationship between TCR avidity, PD-1 expression, and the functional profile of CD8 T cells.


Subject(s)
CD8-Positive T-Lymphocytes/immunology , HIV Infections/immunology , HLA-B Antigens/genetics , Cohort Studies , Cytomegalovirus/immunology , Genotype , HIV Infections/genetics , HIV-1/immunology , HLA-A Antigens/genetics , Herpesvirus 4, Human/immunology , Humans , In Vitro Techniques , Interleukin-2/biosynthesis , Lymphocyte Activation , Orthomyxoviridae/immunology , Receptors, Antigen, T-Cell/metabolism
11.
J Exp Med ; 204(7): 1533-41, 2007 Jul 09.
Article in English | MEDLINE | ID: mdl-17591854

ABSTRACT

It has been recently shown (Seddiki, N., B. Santner-Nanan, J. Martinson, J. Zaunders, S. Sasson, A. Landay, M. Solomon, W. Selby, S.I. Alexander, R. Nanan, et al. 2006. J. Exp. Med. 203:1693-1700.) that the expression of interleukin (IL) 7 receptor (R) alpha discriminates between two distinct CD4 T cell populations, both characterized by the expression of CD25, i.e. CD4 regulatory T (T reg) cells and activated CD4 T cells. T reg cells express low levels of IL-7Ralpha, whereas activated CD4 T cells are characterized by the expression of IL-7Ralpha(high). We have investigated the distribution of these two CD4 T cell populations in 36 subjects after liver and kidney transplantation and in 45 healthy subjects. According to a previous study (Demirkiran, A., A. Kok, J. Kwekkeboom, H.J. Metselaar, H.W. Tilanus, and L.J. van der Laan. 2005. Transplant. Proc. 37:1194-1196.), we observed that the T reg CD25(+)CD45RO(+)IL-7Ralpha(low) cell population was reduced in transplant recipients (P < 0.00001). Interestingly, the CD4(+)CD25(+)CD45RO(+)IL-7Ralpha(high) cell population was significantly increased in stable transplant recipients compared with healthy subjects (P < 0.00001), and the expansion of this cell population was even greater in patients with documented humoral chronic rejection compared with stable transplant recipients (P < 0.0001). The expanded CD4(+)CD25(+)CD45RO(+)IL-7Ralpha(high) cell population contained allospecific CD4 T cells and secreted effector cytokines such as tumor necrosis factor alpha and interferon gamma, thus potentially contributing to the mechanisms of chronic rejection. More importantly, CD4(+)IL-7Ralpha(+)and CD25(+)IL-7Ralpha(+) cells were part of the T cell population infiltrating the allograft of patients with a documented diagnosis of chronic humoral rejection. These results indicate that the CD4(+)CD25(+)IL-7Ralpha(+) cell population may represent a valuable, sensitive, and specific marker to monitor allospecific CD4 T cell responses both in blood and in tissues after organ transplantation.


Subject(s)
CD4 Antigens/immunology , CD4-Positive T-Lymphocytes/immunology , Interleukin-2 Receptor alpha Subunit/immunology , Leukocyte Common Antigens/immunology , Receptors, Interleukin-7/immunology , T-Lymphocytes/immunology , Antigens, CD/immunology , Cytokines/metabolism , Flow Cytometry , Humans , Immunosuppression Therapy , Kidney Transplantation/immunology , Liver Transplantation/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...